Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic Men
NCT05806723 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 104
Last updated 2023-04-10
Summary
The aim of the study was to assess the effect of high intensity statin therapy on testicular and adrenal steroids and vitamin D levels in type 2 diabetes males.It is a prospective study, conducted between march 2021 and July 2022, including 60 men with type 2 diabetes, aged 40 - 65 years, statin-free, and in whom a treatment with high intensity statin was indicated. The patients had two visits, before and six months after a daily intake of 40 mg of atorvastatin. During each visit, they underwent a clinical examination including the Androgen Deficiency in the Aging Male (ADAM) questionnaire and a fasting blood sample was collected for biological and hormonal measurements.
Conditions
- Diabetes Mellitus, Type 2
- Dyslipidemia Associated With Type II Diabetes Mellitus
- Statin Adverse Reaction
- Hypogonadism, Male
- Adrenal Insufficiency
- Vitamin D Deficiency
Interventions
- DRUG
-
Atorvastatin 40 Mg Oral Tablet
daily drug intake during six months
Sponsors & Collaborators
-
Hopital La Rabta
lead OTHER
Principal Investigators
-
Melika Chihaoui, Professor · La rabta hospital
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 40 Years
- Max Age
- 65 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-03-01
- Primary Completion
- 2022-07-30
- Completion
- 2022-09-15
Countries
- Tunisia
Study Locations
More Related Trials
-
Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.
NCT00104572 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Testosteron Replacement Treatment on the Fibroblast Growth Factor-23, Asymmetric Dimethylarginine and Vitamin D Levels in the Congenital Hypogonadotropic Hypogonadism
NCT02111473 ·Status: COMPLETED ·Phase: PHASE4
-
Insulin Sensitivity in Men With the Metabolic Syndrome
NCT00433173 ·Status: SUSPENDED ·Phase: NA
-
Testosterone Replacement in Diabetes With Vascular Disease (Version 2)
NCT00355537 ·Status: COMPLETED ·Phase: PHASE4
-
Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism
NCT03887936 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Testosterone Replacement on the High Density Lipoprotein Cholesterol Subgroups
NCT01454011 ·Status: COMPLETED ·Phase: PHASE4
-
Steady-State Feedback Actions of Testosterone on Luteinizing Hormone Secretion in Young and Older Men
NCT00431197 ·Status: COMPLETED ·Phase: PHASE1
-
Statin Lowering Testosterone and Sexual Function
NCT02612714 ·Status: COMPLETED ·Phase: PHASE4
-
Metabolic Effects of Steroids in Obese Men
NCT00983554 ·Status: UNKNOWN ·Phase: NA
-
Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome
NCT00438321 ·Status: TERMINATED ·Phase: PHASE1
-
Testosterone Replacement in Men With Diabetes and Obesity
NCT01127659 ·Status: COMPLETED ·Phase: PHASE4
-
28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men
NCT00398580 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Estradiol Addback
NCT01862835 ·Status: COMPLETED ·Phase: PHASE1
-
Androgen Deprivation Therapy Study
NCT00743327 ·Status: TERMINATED
-
Hypogonadism in Young Men With Type 2 Diabetes
NCT01155518 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Evaluate the Association of Testosterone Levels With Coronary Artery Calcification
NCT02310659 ·Status: UNKNOWN
-
Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride
NCT00400335 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Hypoglycemic Drugs on Testosterone Levels in Type 2 Diabetes Patients
NCT03982238 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Testosterone Replacement on Insulin Resistance
NCT00487734 ·Status: COMPLETED ·Phase: PHASE4
-
Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome
NCT05586802 ·Status: RECRUITING ·Phase: PHASE3
-
Effect of Androgel on Atherogenesis in Type 2 Diabetic Males With Hypogonadotrophic Hypogonadism
NCT00467987 ·Status: TERMINATED ·Phase: NA
-
Correlation of Serum Adropin to Testosterone and Adiponectin in Obese Men
NCT03724825 ·Status: COMPLETED
-
Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men
NCT00309855 ·Status: COMPLETED ·Phase: PHASE1
-
Anabolic and Inflammatory Responses to Short-Term Testosterone Administration in Older Men
NCT00957801 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Testosterone on Endothelial Function and Microcirculation in Type 2 Diabetic Patients With Hypogonadism
NCT01084369 ·Status: TERMINATED ·Phase: PHASE4